Science Current Events | Science News | Brightsurf.com
 

Combination therapy may be better than radiotherapy alone to treat aggressive brain cancer

February 29, 2016

(PHILADELPHIA) -- Radiotherapy effectively damages brain tumors but the cancer cells can repair themselves in order to live on. Now, researchers at Sidney Kimmel Cancer Center have tested a strategy that combines radiotherapy with a drug that shuts down the ability of tumor to mend themselves.

Researchers say their 12-patient study, published Jan. 29, 2016 online ahead of print in the Journal of Neuro-Oncology, offer enough promise that a more comprehensive, phase 2 clinical trial should be conducted to test the combination therapy for aggressive, recurrent brain cancer.

"We saw synergy between radiotherapy and the agent, panobinostat. Our findings suggest panobinostat makes radiotherapy much more effective," says the study's senior author, Yaacov R. Lawrence, M.D., of the Department of Radiation Oncology at Thomas Jefferson University's Sidney Kimmel Medical College.

All 12 patients tested had high grade gliomas that had recurred after initial radiotherapy. Eight patients had recurrent glioblastoma, and four had recurrent anaplastic astrocytoma. These two forms of aggressive brain cancer represent almost 70 percent of newly diagnosed gliomas, which are diagnosed in about 10,000 patients annually. Despite response to initial radiation, most patients relapse within two years and overall survival is then limited to a year or less.

"There is no standard treatment for recurrent high grade gliomas. At Jefferson, we have a lot of experience with offering a second course of radiation after a patient relapses, in order to increase survival, but we are excited by the promise of a targeted agent that makes initial and repeat radiotherapy more effective," says co-author Adam Dicker, M.D., Ph.D., FASTRO, Chair and Professor of Radiation Oncology, Pharmacology and Experimental Therapeutics at the Sidney Kimmel Medical College.

Panobinostat, approved for use in 2015 for treatment of multiple myeloma, is being tested in a variety of other cancers. It is a histone deacetylase inhibitor that has been shown to modify expression of about eight percent of RNA molecules produced from genes. Modifying RNA changes protein production, unsetting cancer growth. The drug also turns off RAD51, a DNA repair enzyme, Dr. Dicker says.

Researchers found that the highest dose of panobinostat tested in patients was well tolerated, and they observed improved progression-free survival and overall survival.

"The intent of this study was not to demonstrate benefit of the combination therapy, but to test safety. Still, we did note promising activity, which must be validated in further studies," Dr. Lawrence says.

###

Co-authors all represent Thomas Jefferson University and include first author Wenyin Shi, M.D., Ph.D., Joshua D. Palmer, M.D., Maria Werner-Wasik, M.D., David W. Andrews, M.D., James J. Evans, M.D., Jon Glass, M.D., Lyndon Kim, M.D., Voichita Bad-Ad, M.D., Kevin Judy, M.D., Christopher Farrell, M.D., Nicole Simone, M.D., and Haisong Liu, Ph.D.

The study was funded by Novartis, which developed panobinostat. This funding was to the Sidney Kimmel Cancer Center. No author reports a conflict of interest.

Article Reference: Phase I trial of panobinostat and fractionated stereotactic re-irradiation therapy for recurrent high grade gliomas. Shi W, Palmer JD, Werner-Wasik M, Andrews DW, Evans JJ, Glass J, Kim L, Bar-Ad V, Judy K, Farrell C, Simone N, Liu H, Dicker AP, Lawrence YR. J Neurooncol. Jan. 29, 2016. [Epub ahead of print] PMID: 26821711

Thomas Jefferson University


Related Radiotherapy Current Events and Radiotherapy News Articles


Vismodegib in basal cell carcinoma: Added benefit not proven
Vismodegib (trade name: Erivedge) has already been approved since 2013 for the treatment of patients with locally advanced basal cell carcinoma (BCC) or symptomatic metastatic BCC and has already undergone an early benefit assessment according to the Act on the Reform of the Market for Medicinal Products (AMNOG).

Vitamin A may help improve pancreatic cancer chemotherapy
Around 8,800 people in the UK are diagnosed with pancreatic cancer each year. It is known as the UK's deadliest cancer, with a survival rate of just 3 per cent.

Gene therapy against brain cancer
Only a few days ago, the press (especially in English-speaking countries) enthusiastically announced the publication of a study that described in great detail the genetics of breast cancer, a discovery that according to many marks a breakthrough in the battle against this cancer.

Radiotherapy halves deaths from prostate cancer 15 years after diagnosis
A longitudinal Nordic study, comparing the results of hormone (antiandrogen) therapy with or without the addition of local radiotherapy, shows that a combination of treatments halves the risk of death from prostate cancer 15 years after diagnosis.

A better way to diagnose and manage neuroendocrine tumors
A recent study reported in the May issue of the Journal of Nuclear Medicine demonstrates that Ga-68 DOTATATE PET/CT scans are superior to In-111 pentetreotide scans, the current imaging standard in the United States for detecting neuroendocrine tumors (NETS), and could significantly impact treatment management.

Improvements to online health information can help reduce barriers to care for pancreatic cancer
The Internet has become a powerful and important resource for daily life. When patients receive a medical diagnosis, particularly a difficult one like pancreatic cancer, the web can be an essential information tool, helping to enable patients to have meaningful discussions with health care providers.

Failure to publish trial results exposes patients to risks without providing benefits
Although the publication of results of clinical trials carried out in the USA within 12 months of their completion has been mandatory since 2007, an astoundingly high number of Phase III radiotherapy trials did not do so, according to new research to be presented at the ESTRO 35 conference today (Saturday).

Radiotherapy for lung cancer patients is linked to increased risk of non-cancer deaths
Researchers have found that treating patients who have early stage non-small cell lung cancer (NSCLC) with a type of radiotherapy called stereotactic body radiation therapy (SBRT) is associated with a small but increased risk of death from causes other than cancer.

Demand for radiotherapy will rise substantially over next 10 years
The demand for radiotherapy across all European countries will increase by an average of 16% between 2012 and 2025, with the highest expected increase being for prostate cancer cases (24%), according to a new study published in Radiotherapy and Oncology.

UT Southwestern research shows 98 percent cure rate for prostate cancer using SBRT
A five-year study shows that Stereotactic Body Radiation Therapy (SBRT) to treat prostate cancer offers a higher cure rate than more traditional approaches, according to researchers at UT Southwestern Medical Center Harold C. Simmons Comprehensive Cancer Center.
More Radiotherapy Current Events and Radiotherapy News Articles

Tutorials in Radiotherapy Physics: Advanced Topics with Problems and Solutions

Tutorials in Radiotherapy Physics: Advanced Topics with Problems and Solutions
by Patrick N. McDermott (Author)


The Topics Every Medical Physicist Should Know Tutorials in Radiotherapy Physics: Advanced Topics with Problems and Solutions covers selected advanced topics that are not thoroughly discussed in any of the standard medical physics texts. The book brings together material from a large variety of sources, avoiding the need for you to search through and digest the vast research literature. The topics are mathematically developed from first principles using consistent notation. Clear Derivations and In-Depth Explanations The book offers insight into the physics of electron acceleration in linear accelerators and presents an introduction to the study of proton therapy. It then describes the predominant method of clinical photon dose computation: convolution and superposition dose calculation...

Radiotherapy for Head and Neck Cancers: Indications and Techniques

Radiotherapy for Head and Neck Cancers: Indications and Techniques
by K. Kian Ang MD PhD (Author), Adam S. Garden MD (Author)


Long established as a staple reference for all radiation oncologists, Radiotherapy for Head and Neck Cancers: Indications and Techniques is now in its Fourth Edition. This completely updated edition presents the state-of-the-art protocols currently used at the MD Anderson Cancer Center and thoroughly explains the principles, nomenclature, and clinical use of intensity-modulated radiotherapy (IMRT). The first section discusses the practical aspects of external beam therapy, brachytherapy, and endocavitary beam therapy and offers guidelines on patient care before and during radiotherapy. The second section provides detailed coverage of site-specific indications and techniques.

Radiotherapy Treatment Planning: Linear-Quadratic Radiobiology

Radiotherapy Treatment Planning: Linear-Quadratic Radiobiology
by J. Donald Chapman (Author), Alan E. Nahum (Author)


Understand Quantitative Radiobiology from a Radiation Biophysics Perspective In the field of radiobiology, the linear-quadratic (LQ) equation has become the standard for defining radiation-induced cell killing. Radiotherapy Treatment Planning: Linear-Quadratic Radiobiology describes tumor cell inactivation from a radiation physics perspective and offers appropriate LQ parameters for modeling tumor and normal tissue responses. Explore the Latest Cell Killing Numbers for Defining Iso-Effective Cancer Treatments The book compiles radiation mechanism information from biophysical publications of the past 50 years, addressing how ionizing radiation produces the killing of stem cells in human tumors. It presents several physical and chemical parameters that can modulate the radiation response...

Radiotherapy for brain tumors

Radiotherapy for brain tumors


This is a comprehensive learning tool for medical students, residents, and junior attending physicians in radiation oncology. Organized in chapters and sections by site, the book covers in detail the most common brain tumors currently treated with radiotherapy. Emphasis is on treatment recommendations and the evidence behind them. Moreover, this book provides easily accessible information for residents and practitioners in radiation oncology. It presents the most essential information that is immediately required in the clinical setting. Important data of epidemiology, anatomy, pathology, and clinical presentation are highlighted. Key facets of the work-up are listed, followed by staging and/or risk classification systems. Treatment recommendations are discussed based on stage, histology,...

Patient Centered Care in Medical Imaging and Radiotherapy, 1e

Patient Centered Care in Medical Imaging and Radiotherapy, 1e
by Aarthi Ramlaul MA B.Tech. Rad. N.Dip. Rad. (Editor), Martin Vosper MSc HDCR (Editor)


Health investigation and treatment have moved from a clinician-centred approach to a patient-centred approach during the past few decades. Patients are now rightly regarded as empowered and informed users of health services, not passive recipients. Motivated by this philosophical shift, this new book identifies the key issues underpinning the complete delivery of ‘good’ patient care and considers their application in the medical radiation sciences. Taking a UK/European perspective, the authors examine how a holistic approach is related to legislation, human rights and perceived patient needs. Medical imaging and radiotherapy are front line services experienced by vast numbers of patients with acute and chronic medical conditions, including trauma and cancer. The book includes...

Handbook of Radiotherapy Physics: Theory and Practice

Handbook of Radiotherapy Physics: Theory and Practice
by P Mayles (Editor), A Nahum (Editor), J.C Rosenwald (Editor)


Book by

CT Anatomy for Radiotherapy

CT Anatomy for Radiotherapy
by Pete Bridge (Author)


Knowledge of CT anatomy is increasingly vital in daily radiotherapy practice, especially with more widespread use of cross-sectional image-guided radiotherapy (IGRT) techniques. Existing CT anatomy texts are predominantly written for the diagnostic practitioner and do not always address the radiotherapy issues while emphasising structures that are not common to radiotherapy practice. “CT Anatomy for Radiotherapy” is a new radiotherapy-specific text that is intended to prepare the reader for CT interpretation for both IGRT and treatment planning. It is suitable for undergraduate students, qualified therapy radiographers, dosimetrists and may be of interest to oncologists and registrars engaged in treatment planning. All essential structures relevant to radiotherapy are described...

Proton and Charged Particle Radiotherapy

Proton and Charged Particle Radiotherapy
by Thomas F. DeLaney MD (Editor), Hanne M. Kooy MD (Editor)


This volume is the first comprehensive and practical clinical reference on proton and charged particle radiotherapy. The first half of the book explains the treatment delivery systems used, offers detailed guidance on treatment planning techniques, examines key clinical issues in proton radiotherapy, and reviews recent experience with heavier charged particle radiotherapy. The second half of the book offers "how-to" information on treatment of pediatric tumors, lymphomas, and tumors of the central nervous system, eye, skull base, cervical spine, bone and soft tissue, paranasal sinus, nasal cavity, nasopharynx, oropharynx, oral cavity, salivary glands, prostate, lung, gastrointestinal tract, female reproductive tract, and breast. More than 100 full-color illustrations complement the...

Radiotherapy in Practice - Brachytherapy

Radiotherapy in Practice - Brachytherapy
by Peter Hoskin (Author), Catherine Coyle (Author)


Brachytherapy remains an important component of radical radiation therapy in the modern management of cancer. Widespread adoption of remote afterloading now enables brachytherapy to be delivered with minimum exposure to staff and other patients. Technical advances in imaging and computing power have improved the precision of implantation and complex dosimetry can now be achieved in routine practice. The advantages of direct placement of the radiation source into the area to be treated, overcoming the problems of patient and organ movement, together with the dosimetric advantages inherent in brachytherapy, will ensure that modern brachytheraoy continues to provide the optimal means of delivering accurate high does radiation therapy for many patients.

Fully updated for the second...

Practical Radiotherapy Planning Fourth Edition

Practical Radiotherapy Planning Fourth Edition
by CRC Press


Planning is a critical stage of radiotherapy. Careful consideration of the complex variables involved and critical assessment of the techniques available are fundamental to good and effective practice.

First published in 1985, Practical Radiotherapy Planning has, over three editions, established itself as the popular choice for the trainee raditation oncologist and radiographer, providing the 'nuts and bolts' of planning in a practical and accessible manner.

This fourth edition encompasses a wealth of new material, reflecting the radical change in the practice of radiotherapy in recent years. The information contained within the introductory chapters has been expanded and brought up to date, and a new chapter on patient management has been added. CT stimulators, MLC...

© 2017 BrightSurf.com